Faden Lab
@FadenLab
Translational Head and Neck Cancer Genomics | Mass Eye and Ear | Harvard Medical School
I cannot stress this enough: pairing a 4% funding line with the largest cut in NCI history will devastate the future of cancer research - and patients. We would be turning our backs on decades of progress.
Today’s #FDA approval marks a significant step forward for certain patients with head and neck squamous cell carcinoma. Learn more here: merck.us/4e7cEYS
A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers. The test has the potential to be significantly more accurate than current methods, including before symptoms develop, according to new Mass General Brigham…
Thanks to @CBankheadMPT from @medpagetoday for discussing our recent @CCR_AACR #liquid biopsy manuscripts. medpagetoday.com/hematologyonco…
Baş-boyun kanserlerinde likit biyopsi ile erken tanıda en dikkat çekici adım: WGS tabanlı HPV-DeepSeek testi, %98.7 duyarlılık ve özgüllük gösterdi! @FadenLab drozdogan.com/hpvye-bagli-ba…
Happy #NationalDNADay! Today the genomics community connects through education and engagement to celebrate how genomic research is transforming healthcare. Learn more about our services: bit.ly/42UB2Zu
Excited to share our study describing a new liquid biopsy method called RARE-Seq for analyzing cell-free RNA (#cfRNA) that is out today in @Nature. 1/15 rdcu.be/eh1Nt
The university will not surrender its independence or relinquish its constitutional rights. Neither Harvard nor any other private university can allow itself to be taken over by the federal government. hrvd.me/ResearchFundin…
NIH Grants Fueled $95 Billion In FY 2024 Economic Activity, Finds New Report forbes.com/sites/michaelt…
Delighted to share my latest clinical case report published in @TheLancetInfDis from Fudan University, highlighting a case of mistaken identity—sinusitis mimicking meningioma! Thanks to @FadenLab from @MassEyeAndEar @Harvard, the co-first author, for his invaluable guidance
Funding from the @NIH contributed to the development of 354 out of 356 (99.4%) of the new drugs approved by the FDA between 2010 and 2019, and 🚨 100% 🚨 of FDA approved drugs btw 2010-2016. @NIH funding is the backbone of American biomedical innovation. #protecttheNIH
#ctDNA monitoring in #headandNeckCancers patients with #IO ? Maybe predict OR and OS ncbi.nlm.nih.gov/pubmed/39973993
It's clear that many do not understand what @NIH-funded research does to improve health. It's time to revive a study published 10 years ago that provides incredible information about this. link in the comment Every single new drug approved by the FDA from 2010–2016 was built on…
Join us in person for an Update in Head and Neck Cancer: 2025 on April 11-12, 2025. Gain insights from experts on the latest advancements in treatment and care. Visit the HMS Course Catalog to register! cmecatalog.hms.harvard.edu/update-head-an…
Great work Daniel! Excited to share this team science work funded by @NIDCR @MGH_RI @MGHCancerCenter @MassEyeAndEar
Teamwork isn’t just for people—it’s for immune cells too! When immune cells organize into tertiary lymphoid structures (TLS) near the tumor boundary, they can predict response to immunotherapy in HNSCC @svploeg @FadenLab tandfonline.com/doi/full/10.10…
Looking forward to speaking at the @HarvardCFAR meeting on blood-based HPV cancer screening in people living with HIV. @MGHCancerCenter @MGH_RI @NCICancerCtrl @mgh_id
📢🙌#HPV-related cancers & #HIV Sci-symp w/Drs Mugo @KEMRI_Kenya @UW #GlobalHealth @AnnaGiuliano19 @MoffittNews de Lussigny @UNITAID RSVP@ mailchi.mp/aeff287b68c4/h………… Networking 🍝@The_BMC @harvardmed @mgh_id @tufts_id @bwh_id @DanaFarber @HarvardGH @ProvBosCFAR @HarvardChanSPH